This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

2 Ex-Dividend Stocks With Buy Ratings

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

West Pharmaceutical Services

The pharmaceutical delivery components company reported fourth-quarter earnings in February of $18.9 million, or 56 cents a share, up from year-earlier earnings of $5.9 million, or 18 cents.

"Management indicated 2012 guidance reflects $0.08-0.15 earnings per share impact from Crystal Zenith products and other proprietary safety/administration devices," Jefferies analysts wrote in a Feb. 23 report. "However, WST acknowledged these sales depend on non- and pre-commercial customer use, which carries a higher risk that revenue may be lower than expected."

Forward Annual Dividend Yield: 1.8%

Rated "B+ (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin was about the same as it was the previous year.

West Pharmaceutical Services has weak liquidity. Its Quick Ratio is 0.98, which demonstrates a lack of ability to meet its short-term cash needs.

In the fourth quarter, stockholders' net worth increased 4.66% from the prior year.

TheStreet Ratings' price target is $47.64.

-- Written by Alexandra Zendrian



>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to: tips@thestreet.com.

>To follow the writer on Twitter, go to Alexandra Zendrian.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
WST $52.99 -1.70%
VALE $8.80 9.60%
AAPL $126.41 -1.80%
FB $77.66 -1.50%
GOOG $531.84 -1.70%

Markets

DOW 17,937.44 -132.96 -0.74%
S&P 500 2,090.75 -23.74 -1.12%
NASDAQ 4,943.22 -73.7090 -1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs